Goodwill and intangible assets
|12 Months Ended|
Jul. 31, 2018
|Goodwill and Intangible Assets Disclosure [Abstract]|
|Goodwill and Intangible Assets Disclosure [Text Block]||
Note 2 - Goodwill and intangible assets
The Company’s net carrying amount of goodwill is in the Clinical Laboratory Services segment and is $7,452 as of July 31, 2018 and 2017.
The Company’s change in the net carrying amount of intangible assets, all in the Life Sciences Products segment is as follows:
Intangible assets, all finite-lived, consist of the following:
At July 31, 2018 information with respect to the intangibles acquired is as follows:
At July 31, 2018, the weighted average remaining useful life of intangible assets was approximately two years.
Estimated amortization expense related to these finite-lived intangible assets for the five succeeding fiscal years ending July 31 is as follows:
Amortization expense for the years ended July 31, 2018, 2017, and 2016 was $992, $1,520, and $1,677, respectively.
The entire disclosure for goodwill and intangible assets.
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef